Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹186Prev. Close
₹181.65Turnover(Lac.)
₹54.12Day's High
₹187Day's Low
₹17752 Week's High
₹20052 Week's Low
₹40.2Book Value
₹37.41Face Value
₹10Mkt Cap (₹ Cr.)
226.16P/E
33.33EPS
5.39Divi. Yield
016 Aug 2023
12:00 AM
BookCloser
16 Aug 2023
12:00 AM
AGM
Announcement Date: 16 Aug, 2023
22 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 12.59 | 12.59 | 12.04 | 10.19 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 27.97 | 26.7 | 23.05 | 24.1 |
Net Worth | 40.56 | 39.29 | 35.09 | 34.29 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 45.93 | 34.96 | 40.04 | 31.1 |
yoy growth (%) | 31.39 | -12.69 | 28.75 | -12.77 |
Raw materials | -7.57 | -5.17 | -6.97 | -5.71 |
As % of sales | 16.49 | 14.79 | 17.41 | 18.36 |
Employee costs | -13.73 | -12.11 | -13.2 | -9.95 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 3.16 | -3.27 | 0.09 | -2.77 |
Depreciation | -4.55 | -4.35 | -3.9 | -3.59 |
Tax paid | -0.71 | 0.79 | -0.02 | 1.44 |
Working capital | 0.04 | 1.69 | 5.05 | 2.96 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 31.39 | -12.69 | 28.75 | -12.77 |
Op profit growth | 97.03 | -32.85 | 64.98 | -50.64 |
EBIT growth | 280.34 | -61.5 | 110.47 | -69.56 |
Net profit growth | -198.94 | -3,536.19 | -105.42 | -147.74 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,526.7 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,565 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,478.65 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,093.5 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,486.8 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Atul Maheshwari
Whole Time Director & CFO
S M Maheshwari
Independent Non Exe. Director
Pramod Kalani
Independent Non Exe. Director
G K Sarda
Independent Non Exe. Director
Dhaval J Soni
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Lactose (India) Ltd
Summary
Lactose (India) Ltd was incorporated on March 1991 as a Public Limited Company in the Vadodara district of Gujarat. The company is engaged in the manufacturing and trading of pharmaceutical products. They offer edible and pharmaceutical grade lactose, which is used as an ingredient in pharmaceutical products, as well as in the dairy, food, confectionery, and beverage industries. The company also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee. Further, they engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation, Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai, Delhi, Chennai, Bangalore, Calcutta, Hyderabad and Ahmedabad. The company set up a project to manufacture lactose IP/BP grade, an import substitute, with an installed capacity of 465 TPA at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval, Pune, a subsidiary of Alfa Laval, Sweden. In January 1994, the company commenced commercial production of Lactose. In the year 1994, the company undertook an expansion and forward in
Read More
What is the Lactose (India) Ltd share price today?
The Lactose (India) Ltd shares price on nse is Rs.₹179.65 today.
What is the Market Cap of Lactose (India) Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Lactose (India) Ltd is ₹226.16 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Lactose (India) Ltd?
The PE and PB ratios of Lactose (India) Ltd is 33.33 and 4.80 as of 03 Jul ‘24
What is the 52 Week High and Low of Lactose (India) Ltd?
The 52-week high/low is the highest and lowest price at which a Lactose (India) Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Lactose (India) Ltd is ₹40.2 and ₹200 as of 03 Jul ‘24
What is the CAGR of Lactose (India) Ltd?
Lactose (India) Ltd's CAGR for 5 Years at 50.86%, 3 Years at 77.65%, 1 Year at 272.16%, 6 Month at 45.20%, 3 Month at 27.03% and 1 Month at 20.70%.
What is the shareholding pattern of Lactose (India) Ltd?
The shareholding pattern of Lactose (India) Ltd is as follows:
Promoters - 53.65 %
Institutions - 0.62 %
Public - 45.74 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
